Skip to content

The efficacy of High Intensity Focused Electromagnetic (HIFEM) Technology in Treatment of Urinary incontinence women

The efficacy of High Intensity Focused Electromagnetic (HIFEM) Technology in Treatment of Urinary incontinence women

Status
Unknown
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240430002
Enrollment
58
Registered
2024-04-30
Start date
2024-01-15
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary incontinence women Urinary Incontinence, Urge, Stress, mixed

Interventions

High Intensity Focused Electromagnetic (HIFEM) Perform treatment by sitting with your back straight. Feet on the floor, duration 28 minutes per session, 2 times per week. At least 2 days apart for a
Experimental Device

Sponsors

Faculty of Medicine Khon Kaen University Research Fund
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Women with urinary incontinence problems and it interferes with daily life, the combined ICIQ-UI SF score is greater than or equal to 6 points. 2. Patients older than or equal to 20 years old.

Exclusion criteria

Exclusion criteria: 1. Patients with a cardiac pacemaker or nerve stimulation device or having metal implanted in the body 2. Patients undergoing treatment for urinary incontinence with medication. or treated with surgery 3. Patients who have problems with blood diseases coagulation of blood 4. Patients using anticoagulant drugs 5. Patients with pelvic floor prolapse greater than stage 2 6. Pregnant women 7. Patients who cannot read or write Thai or communicate. 8. Patients with fever 9. Cancer patients 10. Heart disease patients 11. Lungs not working properly 12. Patients with electronic implants 13. Patients who are using a medicine pump. 14. After new surgery which muscle contraction interferes with the recovery of the surgical wound 15. Patients with numbness in the pelvic area.

Design outcomes

Primary

MeasureTime frame
Severity of UI patient 3 month after treatment ICIQ-UI SF score

Secondary

MeasureTime frame
Quality of life of UI patient 3 month after treatment IIQ-7 ,Sexual function 3 month after treatment PISQ-IR score

Countries

Thailand

Contacts

Public ContactKamonphan Pinjaroen

Faculty of Medicine,Khon Kaen University

Kamonpi@kku.ac.th0933208907

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026